Module 3 Presentations

07/05/2024

Christian Maasch Head of Quality Regulatory Compliance, Change Control Mgmt & Deputy Quality Systems Lecture 3: Nomenclature and Characterisation of the Active Ingredient

Takeda GmbH, Oranienburg, Germany May 15 th ,2024

Disclaimer: Confidential. For internal use only. The opinions expressed in this presentation and on the following slides are solely those of the presenter and not necessarily those of Takeda. Takeda does not guarantee the accuracy or reliability of the information provided herein.”

The Organisation for Professionals in Regulatory Affairs

1

Takeda: A Global Biopharmaceutical Company

Nomenclature and Characterisation of the Active Ingredient

The Organisation for Professionals in Regulatory Affairs

2